| Date Filed | Type | Description |
| 10/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/03/2023 |
4
| Gassert Chad (SVP - CORP. DEV. & STRATEGY) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Sold 20,000 shares
@ $56.48, valued at
$1.1M
|
|
| 10/02/2023 |
8-K
| Quarterly results |
| 08/25/2023 |
4
| Gutwerg Ori (SVP, GENERICS) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Sold 13,502 shares
@ $62.39, valued at
$842.4k
Sold 2,059 shares
@ $62.39, valued at
$128.5k
Exercised 13,502 options to buy
@ $31.49, valued at
$425.2k
|
|
| 08/25/2023 |
4
| Marken James G. (SVP OPS & PROD DEV) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Sold 3,932 shares
@ $63, valued at
$247.7k
Exercised 3,750 options to buy
@ $40.59, valued at
$152.2k
Exercised 1,667 options to buy
@ $33, valued at
$55k
|
|
| 08/23/2023 |
4
| Leonard Matthew J (Director) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Granted 7,583 shares
@ $0 |
|
| 08/23/2023 |
3
| Leonard Matthew J (Director) has filed a Form 3 on ANI PHARMACEUTICALS INC |
| 08/23/2023 |
8-K
| Appointed a new director |
| 08/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
SC 13D/A
| Meridian Venture Partners II GP, L.P. reports a 9.2% stake in ANI Pharmaceuticals, Inc. |
| 08/16/2023 |
4
| MERIDIAN VENTURE PARTNERS II LP (10% Owner) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Sold 200,000 shares
@ $58.5, valued at
$11.7M
|
|
| 08/16/2023 |
4
| Shanmugam Muthusamy (HEAD OF R&D, COO-NOVITIUM OPS) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Sold 27,890 shares
@ $61.15, valued at
$1.7M
Sold 22,110 shares
@ $61.6, valued at
$1.4M
|
|
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/16/2023 |
4
| CAREY STEPHEN P. (SVP & CFO) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Sold 17,639 shares
@ $61.37, valued at
$1.1M
|
|
| 08/15/2023 |
4
| Pera Antonio R (Director) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Sold 3,000 shares
@ $60.37, valued at
$181.1k
|
|
| 08/15/2023 |
4
| Lalwani Nikhil (PRESIDENT & CEO) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Sold 56,666 shares
@ $57.75, valued at
$3.3M
Sold 11,616 shares
@ $61.13, valued at
$710.1k
Exercised 11,616 options to buy
@ $29, valued at
$336.9k
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
8-K
| Quarterly results |
| 08/03/2023 |
4
| Gassert Chad (SVP - CORP. DEV. & STRATEGY) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Sold 20,000 shares
@ $51.06, valued at
$1M
|
|
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
|